Breaking News Instant updates and real-time market news.

AXNX

Axonics

$33.27

-1.23 (-3.57%)

, MDT

Medtronic

$107.90

0.13 (0.12%)

07:50
09/03/19
09/03
07:50
09/03/19
07:50

Axonics initiated with a Buy at Needham

Needham analyst Mike Matson initiated Axonics (AXNX) with a Buy rating and a price target of $43, citing the company's pending entry into the "large and growing" sacral neuromodulation market and thereby ending the "monopoly" held by Medtronic (MDT) by offering a superior product. The analyst further believes that Axonics' commercial organization and strategy should allow it to capture market share and drive "significant" revenue growth and operating leverage, while warning that Medtronic's competitive response may be "too little, too late."

AXNX

Axonics

$33.27

-1.23 (-3.57%)

MDT

Medtronic

$107.90

0.13 (0.12%)

  • 04

    Sep

  • 09

    Sep

  • 25

    Sep

AXNX Axonics
$33.27

-1.23 (-3.57%)

12/04/18
PIPR
12/04/18
NO CHANGE
Target $25
PIPR
Overweight
Nuvectra approval strategy validated by Axonics filing, says Piper Jaffray
Nuvectra (NVTR) competitor Axonics (AXNX) announced this morning that it has resubmitted a literature-based market approval application for its sacral neuromodulation device, which is different than recent commentary that it would be going down the traditional clearance pathway, Piper Jaffray analyst Matt O'Brien tells investors in a research note. This approach for approval is the same as what Nuvectra is doing to get Virtis cleared and provides "further validation that this strategy is the appropriate one," the analyst adds. He continues to believe Nuvectra is attractive solely based on its spinal cord stimulation business prospects and views Virtis as "another leg of value creation." O'Brien encourages investors to build positions in the name and keeps an Overweight rating on the stock with a $25 price target.
03/05/19
RHCO
03/05/19
NO CHANGE
Target $26
RHCO
Buy
Axonics price target raised to $26 from $20 at SunTrust
SunTrust analyst Bruce Nudell raised his price target on Axonics to $26 and kept his Buy rating ahead of its Q4 earnings, saying his model update reflects the company's submission of positive top line 6-month data from its pivotal ARTISAN trial , to the FDA to further support its literature-based pre-market approval. The analyst contends that the FDA may approve the "literature-based PMA in mid-2019", adding that Axonics also retains the option to file a traditional clinical based PMA in Q1 with an expected FDA approval in Q3. Nudell believes that the company will achieve entrance in the U.S. Sacral Neuromodulation System market in Q3, stating his model now appropriately reflects future FDA approval updates.
05/10/19
RHCO
05/10/19
NO CHANGE
Target $33
RHCO
Buy
Axonics price target raised to $33 from $26 at SunTrust
SunTrust analyst Bruce Nudell raised his price target on Axonics (AXNX) to $33 and kept his Buy rating after its Q1 earnings, saying the results have strengthened his bullish outlook on the stock based on the company's increased market share gains for its sacral neuromodulation device. The analyst anticipates a "rapid share shift" given the device's value proposition - including ability to have a full body MRI and fewer replacements over a 15-year period - over Medtronic's (MDT) "outdated" Interstim II.
07/02/19
WELS
07/02/19
NO CHANGE
Target $47
WELS
Outperform
Axonics price target raised to $47 from $35 at Wells Fargo
Wells Fargo analyst Larry Biegelsen raised his price target for Axonics to $47 from $35 after the results of a large-scale study were published in the Journal of the American Medical Association Internal Medicine, which showed some types of anticholinergic drugs, including bladder antimuscarinics, are associated with an increased risk of dementia. As a result of the data, the analyst expects OAB patients to present for sacral neuromodulation therapy both more quickly and more frequently. His recent physician checks suggest the JAMA data is a potential tailwind that should help further grow the SNM category, and there is a substantial amount of built-up demand for Axonics' r-SNM product. Biegelsen reiterates an Outperform rating on the shares.
MDT Medtronic
$107.90

0.13 (0.12%)

08/21/19
STFL
08/21/19
NO CHANGE
Target $112
STFL
Hold
Medtronic price target raised to $112 from $95 at Stifel
Stifel analyst Rick Wise raised his price target on Medtronic shares to $112 from $95 following the company's "solid outperformance" in Q1, which he said "augurs well" for the year. Medtronic was "perhaps conservative" in reiterating its 4% full-year sales growth outlook, said Wise, who keeps a Hold rating on the stock.
08/21/19
WELS
08/21/19
NO CHANGE
Target $120
WELS
Outperform
Medtronic price target raised to $120 from $110 at Wells Fargo
Wells Fargo analyst Larry Biegelsen raised his price target for Medtronic to $120 from $110 given better than expected Q1 results and as the company affirmed 2020 sales growth and raised EPS guidance. The analyst reiterates an Outperform rating on the shares.
08/21/19
BMOC
08/21/19
NO CHANGE
Target $118
BMOC
Outperform
Medtronic price target raised to $118 from $107 at BMO Capital
BMO Capital analyst Joanne Wuensch raised her price target on Medtronic to $118 and kept her Outperform rating after its above-consensus Q1 results, saying the company appears to finally be positioned to "string together" a series of "consistent good quarters". The analyst adds that Medtronic outperformed in Q1 despite the difficult annual comp and prior to many of its pipeline products starting to gain traction. Wuensh further notes that the company is beginning to see the benefits of cost controls put in place last year as its operating margins expanded by 90bps.
08/21/19
LEHM
08/21/19
NO CHANGE
Target $117
LEHM
Overweight
Medtronic price target raised to $117 from $110 at Barclays
Barclays analyst Kristen Stewart said Medtronic "started this year off on the right note" and she raised her price target on the stock to $117 from $110 to reflect a higher target multiple, more confidence on its pipeline and an increased calendar year 2020 earnings estimate. She keeps an Overweight rating on Medtronic shares, adding that "investors should have a great opportunity to 'kick the tires' with three investor briefings planned" over the next month.

TODAY'S FREE FLY STORIES

PNRL

Paringa Resources

$2.28

-0.06 (-2.56%)

20:18
09/16/19
09/16
20:18
09/16/19
20:18
Hot Stocks
Paringa Resources names Jim Middleton as Executive Advisor »

Paringa Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBNC

Reliant Bancorp

$24.70

0.16 (0.65%)

20:17
09/16/19
09/16
20:17
09/16/19
20:17
Hot Stocks
Reliant Bancorp to buy Tennessee Community Bank Holdings for $37.2M »

Reliant Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

ORCL

Oracle

$53.12

-0.64 (-1.19%)

, INTC

Intel

$52.21

-0.32 (-0.61%)

19:12
09/16/19
09/16
19:12
09/16/19
19:12
Hot Stocks
Intel, Oracle collaborate on Optane DC Persistent Memory »

Intel (INTC) and Oracle…

ORCL

Oracle

$53.12

-0.64 (-1.19%)

INTC

Intel

$52.21

-0.32 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ORCL

Oracle

$53.12

-0.64 (-1.19%)

, VMW

VMware

$155.87

4.81 (3.18%)

19:08
09/16/19
09/16
19:08
09/16/19
19:08
Hot Stocks
VMware, Oracle expand partnership on hybrid cloud »

Oracle (ORCL) and VMware…

ORCL

Oracle

$53.12

-0.64 (-1.19%)

VMW

VMware

$155.87

4.81 (3.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

ACRS

Aclaris Therapeutics

$1.09

0.06 (5.83%)

, BBCP

Concrete Pumping

$4.40

0.265 (6.41%)

19:05
09/16/19
09/16
19:05
09/16/19
19:05
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: Aclaris…

ACRS

Aclaris Therapeutics

$1.09

0.06 (5.83%)

BBCP

Concrete Pumping

$4.40

0.265 (6.41%)

GLW

Corning

$30.04

-0.12 (-0.40%)

XLRN

Acceleron

$44.67

0.75 (1.71%)

SHOP

Shopify

$337.93

-0.77 (-0.23%)

KHC

Kraft Heinz

$29.62

0.37 (1.27%)

PSTV

Plus Therapeutics

$9.51

-0.05 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 18

    Sep

  • 01

    Oct

  • 17

    Oct

  • 17

    Oct

  • 04

    Dec

  • 04

    Apr

  • 17

    Sep

KHC

Kraft Heinz

$29.62

0.37 (1.27%)

19:03
09/16/19
09/16
19:03
09/16/19
19:03
Hot Stocks
3G Capital sells 25.1M shares of Kraft Heinz »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

KHC

Kraft Heinz

$29.62

0.37 (1.27%)

18:53
09/16/19
09/16
18:53
09/16/19
18:53
Hot Stocks
Kraft Heinz's Lemann acquires nearly 3.5M common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

HMSY

HMS Holdings

$37.14

0.24 (0.65%)

18:43
09/16/19
09/16
18:43
09/16/19
18:43
Hot Stocks
HMS Holdings acquires VitreosHealth for approximately $36.5M »

HMS Holdings announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

18:25
09/16/19
09/16
18:25
09/16/19
18:25
General news
U.S. industrial production preview: »

U.S. industrial…

18:25
09/16/19
09/16
18:25
09/16/19
18:25
General news
Treasury Market Summary »

Treasury Market Summary:…

ICAD

iCAD

$6.89

-0.01 (-0.14%)

18:25
09/16/19
09/16
18:25
09/16/19
18:25
Conference/Events
iCAD to hold an investor reception »

Management hosts "An…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

  • 12

    Nov

GLW

Corning

$30.04

-0.12 (-0.40%)

18:18
09/16/19
09/16
18:18
09/16/19
18:18
Hot Stocks
Corning down 5.5% or $1.64 at $28.40 per share after cutting volume outlook »

As part of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

18:17
09/16/19
09/16
18:17
09/16/19
18:17
Periodicals
We Company IPO delayed until October at earliest, WSJ reports »

The We Company's IPO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$30.04

-0.12 (-0.40%)

18:16
09/16/19
09/16
18:16
09/16/19
18:16
Hot Stocks
Corning cuts Q3 volume guidance for Display and Optical Communications units »

Corning is providing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

18:05
09/16/19
09/16
18:05
09/16/19
18:05
Periodicals
Breaking Periodicals news story on We Company »

We Company IPO delayed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$37.21

-1.62 (-4.17%)

18:02
09/16/19
09/16
18:02
09/16/19
18:02
Periodicals
Auto workers strike could cost GM $100M daily, WSJ says »

General Motors could lose…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLNE

Hamilton Lane

$59.95

-0.51 (-0.84%)

17:57
09/16/19
09/16
17:57
09/16/19
17:57
Hot Stocks
Hamilton Lane vice chairman sells 150K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

17:52
09/16/19
09/16
17:52
09/16/19
17:52
Conference/Events
SVB Leerink biotech analysts to hold analyst/industry conference call »

Biotech Analysts discuss…

HLNE

Hamilton Lane

$59.95

-0.51 (-0.84%)

17:52
09/16/19
09/16
17:52
09/16/19
17:52
Hot Stocks
Hamilton Lane chairman sells 78.5K shares of common »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

GD

General Dynamics

$190.91

0.98 (0.52%)

, BAH

Booz Allen

$70.35

0.85 (1.22%)

17:44
09/16/19
09/16
17:44
09/16/19
17:44
Hot Stocks
General Dynamics, Booz Allen and Parsons awarded $427M max Air Force contract »

General Dynamics (GD),…

GD

General Dynamics

$190.91

0.98 (0.52%)

BAH

Booz Allen

$70.35

0.85 (1.22%)

PSN

Parsons

$37.25

0.35 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

T

AT&T

$37.32

-0.58 (-1.53%)

17:43
09/16/19
09/16
17:43
09/16/19
17:43
Periodicals
Suit claims AT&T told employees to make fake DirecTV accounts, Bloomberg says »

According to a lawsuit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

UBER

Uber

$34.42

1.18 (3.55%)

, LYFT

Lyft

$47.78

1.68 (3.64%)

17:39
09/16/19
09/16
17:39
09/16/19
17:39
Periodicals
Uber to limit drivers' app access in NYC to comply with rules, Reuters says »

Uber (UBER) on Tuesday…

UBER

Uber

$34.42

1.18 (3.55%)

LYFT

Lyft

$47.78

1.68 (3.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEE

NextEra Energy

$218.31

-0.19 (-0.09%)

17:36
09/16/19
09/16
17:36
09/16/19
17:36
Conference/Events
NextEra Energy management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 02

    Oct

  • 10

    Nov

  • 10

    Nov

NJR

New Jersey Resources

$44.80

-0.36 (-0.80%)

17:34
09/16/19
09/16
17:34
09/16/19
17:34
Hot Stocks
New Jersey Resources formally appoints Steve Westhoven CEO »

Following New Jersey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEGEF

MEG Energy

$0.00

(0.00%)

17:34
09/16/19
09/16
17:34
09/16/19
17:34
Conference/Events
MEG Energy management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.